SARS_CoV_2 mutation literature information.


  Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil.
 PMID: 34241897       2021       Journal of medical virology
Result: P.1 defining mutations related to each genomic region were the following: ORF1ab: S1188L, K1795Q, E5665D; spike: L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, H655Y, T1027I; Orf8: E92K; and nucleocapsid: P80.


  Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
 PMID: 34281387       2021       mBio
Table: H655Y


  Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach.
 PMID: 34307771       2021       Virusdisease
Abstract: In the mutational analysis, we found 639 mutations in the
Table: H655Y
Discussion: L5F, T22I, T29I, H49Y, L54F, V90F, S98F, S221L, S254F, V367F, A520S, T572I, D614G, H655Y, P809S, A879S, D936Y, A1020S, A1078S, and H1101Y.


  Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants.
 PMID: 34351895       2021       PLoS computational biology
Result: P.1 variant includes the mutations L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I.


  Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021.
 PMID: 34363852       2021       Virus research
Table: H655Y
Discussion: Of the 10 new amino acid mutations in the spike protein (L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, H655Y, T1027I) compared to its immediate ancestor (B.1.1.28), molecular selection analyses found evidence that 8 of these 10 mutations are under diversifying positive selection.


  Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage.
 PMID: 34406867       2021       Journal of virology
Result: 4C demonstrated that the insertion in the NTD and H655Y mutation identified in high-passage-number WA1/2020 did not abrogate furin-mediated processing of S protein.
Result: A second dominant mutation, H655Y, was in the CTD2 domain.
Result: It was less abundant than the above insertion and H655Y mutation and present in a smaller fraction of viral genomes, and its frequency was not increasing.


  The Emergence and Spread of Novel SARS-CoV-2 Variants.
 PMID: 34409009       2021       Frontiers in public health
Table: H655Y


  SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil.
 PMID: 34425504       2021       Diagnostic microbiology and infectious disease
Table: H655Y


  Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern.
 PMID: 34430803       2021       iScience
Method: Antibody preparations were evaluated by SARS-CoV-2 pseudovirus neutralization assay (PsVNA) using WA-1 strain, UK variant (B.1.1.7 with spike mutations: H69-V70del, Y144del, N501Y, A570D, D614G, P681H, T716I, S982A, and D1118H), SA variant (B.1.351 strain with spike mutations L18F, D80A, D215G, L242-244del, R246I, K417N, E484K, N501Y, D614G, and


  ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker.
 PMID: 34433803       2021       Signal transduction and targeted therapy
Method: P.1: L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F.



Browser Board

 Co-occurred Entities




   Filtrator